87048025 - MOLECULAR HEALTH MH GUIDE

Information

  • Trademark
  • 87048025
  • Serial Number
    87048025
  • Registration Number
    5566271
  • Filing Date
    May 24, 2016
    9 years ago
  • Registration Date
    September 18, 2018
    6 years ago
  • Transaction Date
    January 31, 2025
    4 months ago
  • Status Date
    January 31, 2025
    4 months ago
  • Published for Opposition Date
    May 16, 2017
    8 years ago
  • Location Date
    January 31, 2025
    4 months ago
  • First Use Anywhere Date
    June 03, 2016
    9 years ago
  • First Use In Commerce Date
    June 03, 2016
    9 years ago
  • Status Code
    702
  • Current Location
    Historical data usage
    Employee Name
    HISER, CHARLES
  • Attorney Docket Number
    142978.00001
    Attorney Name
    Peter T. Wakiyama
  • Owners
Mark Drawing Code
3
Mark Identification
MOLECULAR HEALTH MH GUIDE
Case File Statements
  • DM0000: The mark consists of the words "MOLECULAR HEALTH" above the larger words "MH GUIDE", the "MH" being in stylized lettering consisting of vertical shapes.
  • GS0091: Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology; downloadable computer databases containing medical and health information on humans; downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for mobile devices, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for accessing databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology
  • GS0381: Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information and records, molecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to online databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and medical or health information or records about or relating to humans and patient specific data, molecular test results, and scientific research for medical diagnostic and treatment purposes; providing access to online software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing access to non-downloadable computer software and algorithms for medical diagnostic and treatment purposes
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Medical consulting services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; consulting services in the fields of medical care, pharmaceuticals and medicine; providing medical information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, and genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
  • DS0000: "MOLECULAR HEALTH GUIDE"
  • GS0421: Consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, life sciences, genomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; consulting and research services in the nature of retrieval, integration, correlation, analysis and interpretation of genomic, sequencing, and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, medical health information patient specific data, molecular test results, data from clinical studies, and scientific research for purposes of scientific, medical and pharmaceutical research; designing and developing searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information and records, molecular test results and patient specific data about or relating to humans for scientific research purposes; providing temporary use to non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for purposes of scientific, medical and pharmaceutical research; providing temporary use to non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for purposes of scientific, medical and pharmaceutical research; providing temporary use to non-downloadable applications for mobile devices, namely, smart phones and tablets, and web applications accessible through the internet providing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology for scientific research purposes; data collection services for scientific research purposes in the fields of genomics, health care, pharmaceuticals, life sciences, bioinformatics, biotechnology and medicine; services for mobile devices, namely, smart phones and tablets, being software design; non-downloadable web applications for accessing databases accessible through the internet in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology; providing temporary use of non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; medical research services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes
Case File Event Statements
  • 9/8/2016 - 8 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/27/2016 - 9 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/1/2016 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/2/2016 - 9 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 9/15/2016 - 8 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/15/2016 - 8 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/15/2016 - 8 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/15/2017 - 8 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/15/2017 - 8 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/16/2017 - 8 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/27/2017 - 8 years ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/27/2017 - 8 years ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/27/2017 - 8 years ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/5/2017 - 8 years ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/5/2017 - 8 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/5/2017 - 8 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/5/2018 - 7 years ago
    23 - PETITION TO REVIVE-GRANTED Type: PETG
  • 4/6/2017 - 8 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/26/2017 - 8 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/16/2017 - 8 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/16/2017 - 8 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/11/2017 - 7 years ago
    21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/11/2018 - 7 years ago
    27 - SOU EXTENSION 1 FILED Type: EXT1
  • 2/5/2018 - 7 years ago
    24 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX
  • 7/11/2018 - 6 years ago
    30 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/16/2018 - 6 years ago
    34 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 2/5/2018 - 7 years ago
    22 - TEAS PETITION TO REVIVE RECEIVED Type: PROA
  • 2/5/2018 - 7 years ago
    25 - NOTICE OF REVIVAL - E-MAILED Type: NREV
  • 2/20/2018 - 7 years ago
    26 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 2/20/2018 - 7 years ago
    28 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 2/21/2018 - 7 years ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/11/2018 - 6 years ago
    31 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 7/11/2018 - 6 years ago
    32 - USE AMENDMENT FILED Type: IUAF
  • 7/24/2018 - 6 years ago
    33 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 9/13/2024 - 8 months ago
    38 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 1/31/2025 - 4 months ago
    39 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 1/31/2025 - 4 months ago
    40 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 1/31/2025 - 4 months ago
    41 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 8/17/2018 - 6 years ago
    35 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 9/18/2018 - 6 years ago
    36 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/18/2023 - a year ago
    37 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1